{"id":11655,"date":"2015-02-11T15:08:09","date_gmt":"2015-02-11T14:08:09","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=11655"},"modified":"2015-02-11T15:08:09","modified_gmt":"2015-02-11T14:08:09","slug":"nous-tractaments-per-a-lhepatitis-c","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/","title":{"rendered":"Nous tractaments per a l\u2019hepatitis C"},"content":{"rendered":"<p>La gran majoria de mitjans de comunicaci\u00f3 s\u2019estan fent ress\u00f2 del debat que estan generant els nous tractaments per a l&#8217;hepatitis C, tant per la seva efic\u00e0cia com pel cost que suposa al sistema sanitari. L\u2019hepatitis C \u00e9s una malaltia infecciosa que afecta exclusivament el fetge i que est\u00e0 produ\u00efda pel virus VHC. Abans d&#8217;identificar-se aquest virus, l&#8217;any 1988, aquesta malaltia rebia el nom d&#8217;hepatitis no A no B. A difer\u00e8ncia de l&#8217;hepatitis A i B,<b> no hi ha vacuna per prevenir l&#8217;hepatitis C. <\/b>Aquest virus \u00e9s una de les principals causes de transplantament de fetge a Catalunya.<\/p>\n<p>El 20% dels casos aguts es curen espont\u00e0niament, per\u00f2 <b>la majoria de les hepatitis C evolucionen cap a la cronicitat<\/b>. En els casos d&#8217;hepatitis cr\u00f2nica, ha estat tractada durant molts anys amb biter\u00e0pia a base d&#8217;interfer\u00f3 i ribavirina durant sis o dotze mesos, amb uns resultats d&#8217;efic\u00e0cia al voltant del 55-60% i amb efectes adversos freq\u00fcents.<\/p>\n<p>Des de fa uns tres anys, han aparegut uns nous f\u00e0rmacs inhibidors de la proteasa que revolucionen el tractament i que, afegits a la biter\u00e0pia, assoleixen <b>curacions de la malaltia al voltant del 80%.<\/b> Estem parlant de <b>boceprevir, telaprevir i simeprevir<\/b>, tractaments que costen al voltant dels 25.000\u20ac. No obstant aix\u00f2, la ind\u00fastria farmac\u00e8utica ha tret al mercat altres grups de medicaments orals com els inhibidors de la polimerasa (sofosbuvir) o els nous inhibidors de la prote\u00efna NS5A (daclatasvir). Aviat sortiran al mercat nous f\u00e0rmacs amb combinaci\u00f3: ombitasvir, paritaprevir\/ritonavir, dasabuvir i ledipasvir.<\/p>\n<figure id=\"attachment_11658\" aria-describedby=\"caption-attachment-11658\" style=\"width: 375px\" class=\"wp-caption alignleft\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-11658 \" alt=\"curshepatitis\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/02\/curshepatitis.jpg\" width=\"375\" height=\"186\" \/><figcaption id=\"caption-attachment-11658\" class=\"wp-caption-text\">D&#8217;esquerra a dreta, la doctora Londo\u00f1o, el doctor Mallolas i la doctora Gorgues<\/figcaption><\/figure>\n<p>Amb l\u2019objectiu d\u2019aprofundir en el coneixement del tractament del VHC, con\u00e8ixer les novetats terap\u00e8utiques i valorar el factor econ\u00f2mic dels nous tractaments, el Col\u00b7legi, conjuntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC), van organitzar el curs \u201cActualitzaci\u00f3 del tractament de la infecci\u00f3 per VHC\u201d l\u201911 de desembre. Es va portar a terme una reflexi\u00f3 conjunta amb diferents especialistes amb punts de vista diversos sobre el paper d\u2019aquests tractaments en terap\u00e8utica tenint en compte aspectes d\u2019efectivitat i cost-efectivitat.<\/p>\n<div class=\"box shadow\">\u201cUn percentatge elevat de pacients VIH tamb\u00e9 es troben infectats pel VHC i cal tractar ambd\u00f3s virus. L&#8217;impacte pressupostari d&#8217;aquests tractaments no \u00e9s menyspreable\u201d, explica <strong>Tom\u00e0s Casasin, vocal d\u2019Hospitals del COFB<\/strong> i coordinador del curs.<\/div>\n<p>La <b>doctora Mar\u00eda Carlota Londo\u00f1o<\/b>, hepat\u00f2loga de l\u2019Hospital Cl\u00ednic de Barcelona va exposar extensament els tractaments actuals m\u00e9s recomanats segons les guies de pr\u00e0ctica cl\u00ednica disponibles i la durada de tractament en funci\u00f3 de les caracter\u00edstiques del pacient a tractar: genotip, grau de fibrosis, na\u00efve o pretractat i, en aquest cas, en funci\u00f3 de la resposta assolida.<\/p>\n<p>El <b>doctor Josep Mallolas<\/b>, cap de l\u2019Hospital de Dia de VIH de l\u2019Hospital, va presentar els darrers estudis del tractament del pacient coinfectats amb els darrers f\u00e0rmacs apareguts i comentats. Finalment, la <b>doctora Maria Queralt Gorgues<\/b>, cap de Servei de Farm\u00e0cia de l&#8217;Hospital Universitari Parc Taul\u00ed de Sabadell, va exposar la repercussi\u00f3 econ\u00f2mica del tractament de l&#8217;hepatitis C en el context del programa de medicaci\u00f3 hospital\u00e0ria de dispensaci\u00f3 ambulat\u00f2ria (MHDA) i dels nous sistemes de finan\u00e7ament on la ind\u00fastria es compromet a obrir els costos del tractament en el cas que aquests siguin superiors al pressupost fixat pel Ministeri.<\/p>\n<p style=\"text-align: center;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/02\/curs_hepatitis.jpg\"><img decoding=\"async\" class=\" wp-image-11657 aligncenter\" alt=\"curs_hepatitis\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2015\/02\/curs_hepatitis.jpg\" width=\"506\" height=\"290\" \/><\/a><\/p>\n<div class=\"box shadow\">\u201cEl tractament de l\u2019hepatitis C \u00e9s un tema d\u2019actualitat apassionant i l&#8217;activa participaci\u00f3 del p\u00fablic assistent ho va deixar pal\u00e8s. El seu tractament canviar\u00e0 novament en un futur molt proper per aconseguir la curaci\u00f3 d&#8217;una malaltia que provoca la major part d&#8217;hepatocarcinomes i de transplantaments hep\u00e0tics. Aix\u00ed mateix, la situaci\u00f3 econ\u00f2mica actual, encara fa m\u00e9s necess\u00e0ria la determinaci\u00f3 d&#8217;acords econ\u00f2mics amb les administracions i l&#8217;elecci\u00f3 dels f\u00e0rmacs m\u00e9s cost-efectius\u201d, explica Casas\u00edn.<\/div>\n<p><span style=\"text-decoration: underline;\"><b><a href=\"http:\/\/canalsalut.gencat.cat\/ca\/home_ciutadania\/salut_az\/h\/hepatitis_c\/\" target=\"_blank\" rel=\"noopener\">M\u00e9s informaci\u00f3 sobre l\u2019hepatitis C al Canal Salut de la Generalitat<\/a><\/b><\/span><\/p>\n<p style=\"text-align: right;\"><strong>Amb el patrocini de:<\/strong><\/p>\n<p style=\"text-align: right;\"><a href=\"http:\/\/www.janssen.es\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"size-full wp-image-6780 alignright\" alt=\"janssen_logo\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/06\/janssen_logo.jpg\" width=\"100\" height=\"49\" \/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La gran majoria de mitjans de comunicaci\u00f3 s\u2019estan fent ress\u00f2 del debat que estan generant els nous tractaments per a l&#8217;hepatitis C, tant per la seva efic\u00e0cia com pel cost que suposa al sistema sanitari. L\u2019hepatitis C \u00e9s una malaltia infecciosa que afecta exclusivament el fetge i que est\u00e0 produ\u00efda [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11658,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[480,218],"class_list":["post-11655","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-farmacia-hospitalaria","tag-hepatitis"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nous tractaments per a l\u2019hepatitis C - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nous tractaments per a l\u2019hepatitis C - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"La gran majoria de mitjans de comunicaci\u00f3 s\u2019estan fent ress\u00f2 del debat que estan generant els nous tractaments per a l&#8217;hepatitis C, tant per la seva efic\u00e0cia com pel cost que suposa al sistema sanitari. L\u2019hepatitis C \u00e9s una malaltia infecciosa que afecta exclusivament el fetge i que est\u00e0 produ\u00efda [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-02-11T14:08:09+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Nous tractaments per a l\u2019hepatitis C\",\"datePublished\":\"2015-02-11T14:08:09+00:00\",\"dateModified\":\"2015-02-11T14:08:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/\"},\"wordCount\":717,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"farm\u00e0cia hospital\u00e0ria\",\"hepatitis\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/\",\"name\":\"Nous tractaments per a l\u2019hepatitis C - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2015-02-11T14:08:09+00:00\",\"dateModified\":\"2015-02-11T14:08:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nous tractaments per a l\u2019hepatitis C\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nous tractaments per a l\u2019hepatitis C - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/","og_locale":"ca_ES","og_type":"article","og_title":"Nous tractaments per a l\u2019hepatitis C - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"La gran majoria de mitjans de comunicaci\u00f3 s\u2019estan fent ress\u00f2 del debat que estan generant els nous tractaments per a l&#8217;hepatitis C, tant per la seva efic\u00e0cia com pel cost que suposa al sistema sanitari. L\u2019hepatitis C \u00e9s una malaltia infecciosa que afecta exclusivament el fetge i que est\u00e0 produ\u00efda [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2015-02-11T14:08:09+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Nous tractaments per a l\u2019hepatitis C","datePublished":"2015-02-11T14:08:09+00:00","dateModified":"2015-02-11T14:08:09+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/"},"wordCount":717,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#primaryimage"},"thumbnailUrl":"","keywords":["farm\u00e0cia hospital\u00e0ria","hepatitis"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/","url":"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/","name":"Nous tractaments per a l\u2019hepatitis C - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#primaryimage"},"thumbnailUrl":"","datePublished":"2015-02-11T14:08:09+00:00","dateModified":"2015-02-11T14:08:09+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2015\/02\/11\/nous-tractaments-per-a-lhepatitis-c\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Nous tractaments per a l\u2019hepatitis C"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"La gran majoria de mitjans de comunicaci\u00f3 s\u2019estan fent ress\u00f2 del debat que estan generant els nous tractaments per a l&#8217;hepatitis C, tant per la seva efic\u00e0cia com pel cost que suposa al sistema sanitari. L\u2019hepatitis C \u00e9s una malaltia infecciosa que afecta exclusivament el fetge i que est\u00e0 produ\u00efda [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/11655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=11655"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/11655\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=11655"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=11655"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=11655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}